Cytosorbents CORP (CTSO) — 10-Q Filings

All 10-Q filings from Cytosorbents CORP. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Cytosorbents Narrows 9-Month Loss to $2.7M on Revenue Growth — Nov 13, 2025 Risk: high
Cytosorbents Corp (CTSO) reported a net loss of $3.17 million for the three months ended September 30, 2025, a slight increase from the $2.77 million net loss i
Cytosorbents' Q2 Loss Widens to $7.5M Amid Revenue Dip — Aug 7, 2025 Risk: high
Cytosorbents Corp reported a net loss of $7.5 million for the three months ended June 30, 2025, a significant increase from the $5.2 million net loss in the pri
Cytosorbents Corp Files Q1 2025 10-Q — May 14, 2025 Risk: medium
Cytosorbents Corporation filed a 10-Q for the period ending March 31, 2025. The company, formerly known as MedaSorb Technologies CORP, is based in Princeton, NJ
Cytosorbents Corp Files Q3 2024 10-Q — Nov 7, 2024 Risk: medium
Cytosorbents Corp filed a 10-Q for the period ending September 30, 2024. The company reported financial results and provided updates on its business operations.
Cytosorbents Corp Q2 2024 Update: Revenue and Cash Position — Aug 13, 2024 Risk: medium
Cytosorbents Corp filed its 10-Q for the period ending June 30, 2024. The company reported $8.46 million in revenue for the six months ended June 30, 2024. Key
Cytosorbents Corp Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: low
Cytosorbents Corp (CTSO) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Cytosorbents Corp reported total assets of $54.29M and total debt of $0 fo

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX